BRKR cites strong order growth and AI automation for future leadership
BRKR says strong order growth in China and tech markets, alongside AI-driven automation, supports future leadership, while revenue timing is affected by complex contracts. Integration of NMR and mass spectrometry systems is part of advanced drug discovery expansion.